Literature DB >> 9367764

Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2.

A G Ladurner1, L S Itzhaki, G de Prat Gay, A R Fersht.   

Abstract

Chymotrypsin inhibitor 2 (CI2) folds kinetically as a single domain protein. It has been shown that elements of native secondary structure do not significantly form in fragments as the 64 residue protein is progressively increased in length from its N terminus, until at least 60 residues are present. Here, we analyse peptides of increasing length from the C terminus and find that native-like structure is not present even in the largest, fragment (7-64). We have examined sets of peptides of the form (1 - x) and ((x + 1)-64) to detect complementation. The only pair that readily complements and gives native-like structure is (1-40) and (41-64), where cleavage occurs in the protease-binding loop of CI2. But, all the pairs of peptides (1 - x) + (41-64) complement for x > 40, as do all pairs of (1-40) + (x-64), where x < 40. The resultant complexes appear to be equivalent to (1-40). (41-64) with the overlapping sequence being unstructured. Thus, the folding of CI2 is extremely co-operative, and interactions have to be made between subdomains (1-40) and (41-64). This is consistent with the mechanism proposed for the folding pathway of intact CI2 in which a diffuse nucleus is formed in the transition state between the alpha-helix in the N-terminal region of the protein and conserved hydrophobic contacts in the C-terminal region of the polypeptide. It is with these protein design features that CI2 can be an effective protease inhibitor.

Mesh:

Substances:

Year:  1997        PMID: 9367764     DOI: 10.1006/jmbi.1997.1303

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  Folding funnels, binding funnels, and protein function.

Authors:  C J Tsai; S Kumar; B Ma; R Nussinov
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

2.  Distinguishing between sequential and nonsequentially folded proteins: implications for folding and misfolding.

Authors:  C J Tsai; J V Maizel; R Nussinov
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

3.  Combinatorial protein engineering by incremental truncation.

Authors:  M Ostermeier; A E Nixon; J H Shim; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Reconstitution of a native-like SH2 domain from disordered peptide fragments examined by multidimensional heteronuclear NMR.

Authors:  D D Ojennus; M R Fleissner; D S Wuttke
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

5.  HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.

Authors:  Iris Cadima-Couto; Nuno Saraiva; Ana Catarina C Santos; Joao Goncalves
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-29       Impact factor: 4.147

Review 6.  The topomer search model: A simple, quantitative theory of two-state protein folding kinetics.

Authors:  Dmitrii E Makarov; Kevin W Plaxco
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

7.  High-affinity fragment complementation of a fibronectin type III domain and its application to stability enhancement.

Authors:  Sanjib Dutta; Vincent Batori; Akiko Koide; Shohei Koide
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

Review 8.  Single-molecule fluorescence studies of protein folding and conformational dynamics.

Authors:  Xavier Michalet; Shimon Weiss; Marcus Jäger
Journal:  Chem Rev       Date:  2006-05       Impact factor: 60.622

9.  A Single Protein Disruption Site Results in Efficient Reassembly by Multiple Engineering Methods.

Authors:  Jeung-Hoi Ha; Maria F Presti; Stewart N Loh
Journal:  Biophys J       Date:  2019-06-07       Impact factor: 4.033

10.  Random dissection to select for protein split sites and its application in protein fragment complementation.

Authors:  Yong Chen; Shuang Li; Tingjian Chen; Hui Hua; Zhanglin Lin
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.